Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prednisolone plus tacrolimus versus prednisolone plus azathioprine for pemphigus vulgaris
IRCT2012073010450N1Phase 3Completed
- Sponsor
- Shiraz University of Medical Sciences
- Start
- Apr 2010
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of prednisolone, tacrolimus and azathioprine in pemphigus vulgaris (PV) (2 arms), sponsored by Shiraz University of Medical Sciences. Started Apr 2010; status: completed.
02
Drugs
prednisolonetacrolimusazathioprine
03
Conditions
pemphigus vulgaris (PV)
Beyond the preview
Go deeper on IRCT2012073010450N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2012073010450N1.